Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
People born in 1981 invited for COVID-19 vaccination As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).
More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.